A clinically-oriented foundation model for intraoperative pathology
Intraoperative pathology is pivotal to precision surgery, yet its clinical impact is constrained by diagnostic complexity and the limited availability of high-quality frozen-section data. While computational pathology has made significant strides, the lack of large-scale, prospective validation has impeded its routine adoption in surgical workflows. Here, we introduce CRISP, a clinically oriented foundation model developed on over 100,000 frozen sections from ten medical centers, specifically designed to provide Clinically-oriented Robust Intraoperative Support for Pathology (CRISP). CRISP was comprehensively evaluated on more than 15,000 intraoperative slides across nearly 100 retrospective diagnostic tasks, including benign-malignant discrimination, key intraoperative decision-making, and pan-cancer detection, etc. The model demonstrated robust generalization across 6 institutions, 14 tumor types, and 24 anatomical sites-including previously unseen sites and rare cancers. In a prospective cohort of over 3,000 patients, CRISP sustained high diagnostic accuracy under real-world conditions, directly informing surgical decisions in 92.6% of cases. Human-AI collaboration further reduced diagnostic workload by 35%, avoided 105 ancillary tests and enhanced detection of micrometastases with 87.5% accuracy. Together, these findings suggest that CRISP represents a clinically oriented approach to AI-driven intraoperative pathology, with the potential to support surgical decision-making and facilitate the translation of computational methods into clinical practice. CRISP, a vision-based pathology foundation model developed exclusively from frozen section slides, supports treatment decision-making throughout the surgical workflow with superior performance to current foundation models and extensive validation, including in a prospective cohort.
Authors
- Muyan Cai (ORCID: https://orcid.org/0000-0002-4646-4391)
- Bing Chu
- Jiabo Ma (ORCID: https://orcid.org/0000-0001-8532-4466)
- Ziqi Zeng (ORCID: https://orcid.org/0000-0002-0539-6193)
- Xueyi Zheng (ORCID: https://orcid.org/0000-0003-1386-7052)
- Ronggang Li (ORCID: https://orcid.org/0000-0001-7126-0182)
- Yu Wang (ORCID: https://orcid.org/0000-0002-2842-0336)
- Dan Xie (ORCID: https://orcid.org/0000-0003-2242-3138)
- Jiangyu Zhang (ORCID: https://orcid.org/0000-0003-1714-3684)
- Yaping Ye (ORCID: https://orcid.org/0000-0001-5376-0124)
- Yihui Wang (ORCID: https://orcid.org/0009-0002-7606-9816)
- Hao Chen (ORCID: https://orcid.org/0000-0002-8400-3780)
- Ke Zheng (ORCID: https://orcid.org/0000-0002-4558-6039)
- Xinke Zhang (ORCID: https://orcid.org/0000-0002-3527-2140)
- Yu Wen (ORCID: https://orcid.org/0000-0002-0288-0684)
- Jiajia Meng (ORCID: https://orcid.org/0000-0002-1001-3417)
- Jiewei Chen
- Xiaoqing Li
- Chengyou Zheng
- Jing Li
- Zihan Zhao
- Xiaobo Wen
- Fengtao Zhou
Institutions
- Sun Yat-sen University (CN)
- Hong Kong University of Science and Technology (HK)
- Nanfang Hospital (CN)
- Zhongshan People's Hospital (CN)
- Zhujiang Hospital (CN)
- Dongguan People’s Hospital (CN)
- Huizhou Central People's Hospital (CN)
- Sun Yat-sen University Cancer Center (CN)
- Jiangmen Central Hospital (CN)
- Southern Medical University (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- Nature Medicine
- Published
- 2026-09-10
- DOI
- https://doi.org/10.1038/s41591-026-04703-0
- Primary Topic
- AI in cancer detection
- Type
- article
- Field-Weighted Citation Impact
- 0.00